ENTITY

Pharmaron Beijing (300759 CH)

74

Analysis

Health Care • China

Pharmaron Beijing Co., Ltd. engages in discovery, development, and manufacturing spectrum for small molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices and clinic research. The Company offers laboratory, clinical development, chemistry manufactory and control, and other services. Pharmaron Beijing conducts businesses based in China.

more

Refresh

Focused

bullish•Pharmaron Beijing

•04 Nov 2019 02:13

Pharmaron Beijing IPO: Solid 9M19, but Is It Good Enough?

Pharmaron Beijing Co., Ltd. (A) (300759 CH) is a global contract research organisation (CRO) and is one of the top three drug discovery service...

Arun George

407 Views

Share

bullish•Pharmaron Beijing

•29 Aug 2019 20:55

Pharmaron Beijing IPO Initiation: Clinically Sound

Pharmaron Beijing Co., Ltd. (A) (300759 CH) is a global contract research organisation (CRO) and is one of the top three drug discovery service...

Arun George

537 Views

Share

bullish•Pharmaron Beijing

•28 Aug 2019 10:58

Pharmaron (康龙化成) A+H Listing: A Leading Drug Discovery Company

Pharmaron, a leading contract research company, is looking to list on the H-Share market by raising up to USD 600 million. In this insight, we will...

Ke Yan, CFA, FRM

644 Views

Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x